tiprankstipranks
Trending News
More News >
Entero Therapeutics (ENTO)
NASDAQ:ENTO
US Market

Entero Therapeutics (ENTO) Technical Analysis

Compare
1,276 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Entero Therapeutics’s (ENTO) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Entero Therapeutics is a Sell.
Entero Therapeutics’s (ENTO) 20-Day exponential moving average is 0.38, while Entero Therapeutics’s (ENTO) share price is $0.4, making it a Buy.
Entero Therapeutics’s (ENTO) 50-Day exponential moving average is 0.43, while Entero Therapeutics’s (ENTO) share price is $0.4, making it a Sell.

Entero Therapeutics (ENTO) Pivot Points

May 09, 2025, 11:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.34
0.35
0.36
0.38
0.39
0.41
0.42
Fibonacci
0.35
0.36
0.37
0.38
0.39
0.39
0.41
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Entero Therapeutics (ENTO) Moving Averages

May 09, 2025, 11:49 AM
Period
Simple
Exponential
MA5
0.37Buy
0.38Buy
MA10
0.36Buy
0.37Buy
MA20
0.37Buy
0.38Buy
MA50
0.45Sell
0.43Sell
MA100
0.50Sell
0.51Sell
MA200
0.50Sell
0.71Sell
Entero Therapeutics’s (ENTO) 10-Day exponential moving average is 0.37, while Entero Therapeutics’s (ENTO) share price is $0.4, making it a Buy.
Entero Therapeutics’s (ENTO) 100-Day exponential moving average is 0.51, while Entero Therapeutics’s (ENTO) share price is $0.4, making it a Sell.
Entero Therapeutics’s (ENTO) stock price is $0.4 and Entero Therapeutics’s (ENTO) 50-day simple moving average is 0.45, creating a Sell signal.
Entero Therapeutics’s (ENTO) stock price is $0.4 and Entero Therapeutics’s (ENTO) 100-day simple moving average is 0.50, creating a Sell signal.
Entero Therapeutics’s (ENTO) stock price is $0.4 and Entero Therapeutics’s (ENTO) 200-day simple moving average is 0.50, creating a Sell signal.

Entero Therapeutics (ENTO) Technical Indicators

May 09, 2025, 11:49 AM
Name
Value
Implied Action
RSI (14)
50.60
Neutral
STOCH (9,6)
73.51
Neutral
STOCHRSI (14)
69.62
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
18.16
Buy
Williams %R
-20.62
Buy
CCI (14)
86.62
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
59.97
Neutral
ROC
5.26
Buy
Entero Therapeutics’s (ENTO) Relative Strength Index (RSI) is 50.60, creating a Neutral signal.
Entero Therapeutics’s (ENTO) Trend Strength Indicator (ADX) is 18.16, creating a Buy signal.
Entero Therapeutics’s (ENTO) Commodity Channel Index (CCI) is 86.62, creating a Neutral signal.
Entero Therapeutics’s (ENTO) Price Rate of Change (ROC) is 5.26, creating a Buy signal.

FAQ

Is ENTO a Buy, Hold, or Sell?
Based on ENTO’s technical indicators, ENTO is a Buy.
    What is ENTO’s RSI (14)?
    ENTO’s RSI (14) is 50.60, which suggests ENTO is a Neutral.
      What is ENTO’s MACD?
      ENTO’s MACD is -0.02, which suggests ENTO is a Sell.
        What is ENTO’s 5-day moving average?
        ENTO’s 5-day moving average is 0.37, which suggests ENTO is a Buy.
          What is ENTO’s 20-day moving average?
          ENTO 20-day moving average is 0.37, which suggests ENTO is a Buy.
            What is ENTO’s 50-day moving average?
            ENTO’s 50-day moving average is 0.45, which suggests ENTO is a Sell.
              What is ENTO’s 200-day moving average?
              ENTO’s 200-day moving average is 0.50, which suggests ENTO is a Sell.
                What is ENTO’s Williams % R (14)?
                ENTO’s Williams % R (14) is -20.62, which suggests ENTO is a Buy.
                  What is ENTO’s CCI (14)?
                  ENTO’s CCI (14) is 86.62, which suggests ENTO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis